Continuing Pharmacy Education
CE: New options when statins are not enoughThe goal of this activity is to prepare pharmacists with the knowledge they need to provide contemporary pharmacologic therapy to patients with hyperlipidemia.
In this issue
Alzheimer's Disease: Untapped Potential for Pharmacy January 18, 2017By Jill SederstromPharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here. Get ready for the new USP hazardous medications standards January 20, 2017By Valerie DeBenedetteSome ASHP members are already in good shape; but 20% agree that “We are in trouble.” Why consumers trust pharmacists January 20, 2017By Christine BlankAmericans ranked pharmacists second only to nurses in a Gallup survey about trusted professions. Ascension honored for enhancing medication safetyThe St Louis-based company received the Institute for Safe Medication Practices Cheers Award. How You Can Help Prevent Opioid Abuse January 24, 2017By Christine BlankPharmacists are on the front lines of helping to curb abuse and misuse in the opioid epidemic. But how can you make this happen in the real world? Chains Step up Efforts Against Drug AbuseNaloxone can now be dispensed without a prescription in 33 states and Washington, DC. Here's how two big pharmacy chains are making the livesaving opioid antagonist more accessible. Automated Dispensing Systems -- One High-Tech Solution January 25, 2017By Anthony VecchioneHealth system pharmacies that require large-scale deployment of automated dispensing cabinets are faced with multiple challenges. Here's one solution. Finding Time to Counsel Patients: Make It the Priority January 26, 2017By Valerie DeBenedetteEvery community pharmacist has the long lines and phones ringing off the hook. But there are ways to find time o counsel patients even when it is busy. A Strategy to Boost Medication Compliance January 27, 2017By Anthony VecchioneLooking for ways to increase medication compliance by challenging patients -- such as the elderly and those with mental illness? PCSK9 Inhibitors: The First of Their KindThe first of their kind, evolocumab and alirocumab belong to a new class of cholesterol lowering agents. Dietary supplements-- an FDA primerFDA is not authorized to review dietary supplements for safety and effectiveness before they go on the market. But it does provide an electronic safety reporting portal tailored exclusively for dietary supplements. First Do No HarmThe tools for improving quality are available to almost every pharmacist and pharmacy technician, whose job is to make the system work. But this may be the weakness in pharmacy’s march to quality.